Literature DB >> 21865300

The selective footprints of viral pressures at the human RIG-I-like receptor family.

Estelle Vasseur1, Etienne Patin, Guillaume Laval, Sandra Pajon, Simona Fornarino, Brigitte Crouau-Roy, Lluis Quintana-Murci.   

Abstract

The RIG-I-like receptors (RLRs)--RIG-I, IFIH1 (or MDA5) and LGP2--are thought to be key actors in the innate immune system, as they play a major role in sensing RNA viruses in the cytosol of host cells. Despite the increasingly recognized importance of the RLR family in antiviral immunity, no population genetic studies have yet attempted to compare the evolutionary history of its different members in humans. Here, we characterized the levels of naturally occurring genetic variation in the RLRs in a panel of individuals of different ethnic origins, to assess to what extent natural selection has acted on this family of microbial sensors. Our results show that amino acid-altering variation at RIG-I, particularly in the helicase domain, has been under stronger evolutionary constraint than that at IFIH1 and LGP2, reflecting an important role for RIG-I in sensing numerous RNA viruses and/or functional constraints related to the binding of viral substrates. Such evolutionary constraints have been much more relaxed at IFIH1 and LGP2, which appear to have evolved adaptively in specific human populations. Notably, we identified several mutations showing signatures of positive selection, including two non-synonymous polymorphisms in IFIH1 (R460H and R843H) and one in LGP2 (Q425R), suggesting a selective advantage related to the sensing of RNA viruses by IFIH and to the regulatory functions of LGP2. In light of the fact that some of these mutations have been associated with altered risks of developing autoimmune disorders, our study provides an additional example of the evolutionary conflict between infection and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865300     DOI: 10.1093/hmg/ddr377

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  Genomic Signatures of Selective Pressures and Introgression from Archaic Hominins at Human Innate Immunity Genes.

Authors:  Matthieu Deschamps; Guillaume Laval; Maud Fagny; Yuval Itan; Laurent Abel; Jean-Laurent Casanova; Etienne Patin; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2016-01-07       Impact factor: 11.025

2.  Variation in PTX3 is associated with primary graft dysfunction after lung transplantation.

Authors:  Joshua M Diamond; Nuala J Meyer; Rui Feng; Melanie Rushefski; David J Lederer; Steven M Kawut; James C Lee; Edward Cantu; Rupal J Shah; Vibha N Lama; Sangeeta Bhorade; Maria Crespo; Ejigayehu Demissie; Joshua Sonett; Keith Wille; Jonathan Orens; Ann Weinacker; David Weill; Selim Arcasoy; Pali D Shah; John A Belperio; David Wilkes; Lorraine B Ware; Scott M Palmer; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2012-07-19       Impact factor: 21.405

3.  Report of four new patients with protein-truncating mutations in C6orf221/KHDC3L and colocalization with NLRP7.

Authors:  Ramesh Reddy; Elie Akoury; Ngoc Minh Phuong Nguyen; Omar A Abdul-Rahman; Christine Dery; Neerja Gupta; William P Daley; Asangla Ao; Hanene Landolsi; Rosemary Ann Fisher; Isabelle Touitou; Rima Slim
Journal:  Eur J Hum Genet       Date:  2012-12-12       Impact factor: 4.246

4.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

5.  The evolutionary landscape of cytosolic microbial sensors in humans.

Authors:  Estelle Vasseur; Michele Boniotto; Etienne Patin; Guillaume Laval; Hélène Quach; Jeremy Manry; Brigitte Crouau-Roy; Lluis Quintana-Murci
Journal:  Am J Hum Genet       Date:  2012-06-28       Impact factor: 11.025

6.  Positive evolutionary selection on the RIG-I-like receptor genes in mammals.

Authors:  Ana Lemos de Matos; Grant McFadden; Pedro J Esteves
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

7.  Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production.

Authors:  Julio E Molineros; Amit K Maiti; Celi Sun; Loren L Looger; Shizhong Han; Xana Kim-Howard; Stuart Glenn; Adam Adler; Jennifer A Kelly; Timothy B Niewold; Gary S Gilkeson; Elizabeth E Brown; Graciela S Alarcón; Jeffrey C Edberg; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vilá; Barry I Freedman; Betty P Tsao; Lindsey A Criswell; Chaim O Jacob; Jason H Moore; Timothy J Vyse; Carl L Langefeld; Joel M Guthridge; Patrick M Gaffney; Kathy L Moser; R Hal Scofield; Marta E Alarcón-Riquelme; Scott M Williams; Joan T Merrill; Judith A James; Kenneth M Kaufman; Robert P Kimberly; John B Harley; Swapan K Nath
Journal:  PLoS Genet       Date:  2013-02-18       Impact factor: 5.917

8.  Duck RIG-I CARD Domain Induces the Chicken IFN-β by Activating NF-κB.

Authors:  Yang Chen; Zhengyang Huang; Bin Wang; Qinming Yu; Ran Liu; Qi Xu; Guobin Chang; Jiatong Ding; Guohong Chen
Journal:  Biomed Res Int       Date:  2015-03-30       Impact factor: 3.411

9.  A deletion polymorphism in the Caenorhabditis elegans RIG-I homolog disables viral RNA dicing and antiviral immunity.

Authors:  Alyson Ashe; Tony Bélicard; Jérémie Le Pen; Peter Sarkies; Lise Frézal; Nicolas J Lehrbach; Marie-Anne Félix; Eric A Miska
Journal:  Elife       Date:  2013-10-08       Impact factor: 8.140

10.  Ancient origins of vertebrate-specific innate antiviral immunity.

Authors:  Krishanu Mukherjee; Bryan Korithoski; Bryan Kolaczkowski
Journal:  Mol Biol Evol       Date:  2013-10-08       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.